Literature DB >> 18997105

Betaig-h3 interacts with alpha3beta1 integrin to promote adhesion and migration of human hepatoma cells.

Juan Tang1, Ya-Mei Wu, Pu Zhao, Jian-Li Jiang, Zhi-Nan Chen.   

Abstract

betaig-h3 is a TGF-induced extracellular matrix (ECM) protein. Our previous evidence suggests that beta ig-h3 may promote adhesion and invasion potential of human hepatoma cells, but the mechanism underlying this process is still unknown. The present study identifies a pivotal role for molecules of the beta ig-h3 signal transduction pathway. We demonstrated that beta ig-h3 co-immunoprecipitated with alpha 3beta 1 integrin in human 7721 hepatoma cells. The addition of alpha 3beta 1 integrin antibodies inhibited the elevated adhesion and migration in beta ig-h3-over-expressing 7721 cells, but not in beta ig-h3 siRNA transfected 7721 cells. The expression and activity of integrin downstream molecules FAK and paxillin show a positive correlation with beta ig-h3 expression in different human hepatoma cells. Levels of focal adhesions and stress fibers were decreased in beta ig-h3 siRNA transfected 7721 cells. We suggest that by interaction with alpha 3beta 1 integrin, beta ig-h3 activates FAK-paxillin signaling linkage, leads to cytoskeleton reorganization, and thus enhances the metastatic potentials of human hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18997105     DOI: 10.3181/0806-RM-187

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  13 in total

Review 1.  Calcium signaling in the liver.

Authors:  Maria Jimena Amaya; Michael H Nathanson
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

2.  Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3.

Authors:  Sang Hun Shin; Jaeyoon Kim; Soon Chul Heo; Yang Woo Kwon; Young Mi Kim; In-San Kim; Taehoon G Lee; Jae Ho Kim
Journal:  Mol Cell Proteomics       Date:  2011-12-07       Impact factor: 5.911

3.  Inhibition of human scleral fibroblast cell attachment to collagen type I by TGFBIp.

Authors:  Lilian Shelton; Jody A Summers Rada
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-22       Impact factor: 4.799

4.  Human U87 astrocytoma cell invasion induced by interaction of βig-h3 with integrin α5β1 involves calpain-2.

Authors:  Jie Ma; Wei Cui; Shi-ming He; Yong-hong Duan; Li-Jun Heng; Liang Wang; Guo-dong Gao
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

5.  The role of TGFBI (βig-H3) in gastrointestinal tract tumorigenesis.

Authors:  Bing Han; Haolei Cai; Ying Chen; Bing Hu; Hongyu Luo; Yulian Wu; Jiangping Wu
Journal:  Mol Cancer       Date:  2015-03-24       Impact factor: 27.401

6.  Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model.

Authors:  Nathalie Allaman-Pillet; Anne Oberson; Daniel F Schorderet
Journal:  Oncotarget       Date:  2017-02-28

7.  Migration of breast cancer cell lines in response to pulmonary laminin 332.

Authors:  Philip M Carpenter; Priyanka Sivadas; Spencer S Hua; Cally Xiao; Alyssa B Gutierrez; Tuan Ngo; Paul D Gershon
Journal:  Cancer Med       Date:  2016-11-22       Impact factor: 4.452

Review 8.  Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.

Authors:  Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

9.  βig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin α2β1 and activating PI3K signaling pathway.

Authors:  Yun-Shan Guo; Rui Zhao; Jie Ma; Wei Cui; Zhen Sun; Bo Gao; Shu He; Yue-Hu Han; Jing Fan; Liu Yang; Juan Tang; Zhuo-Jing Luo
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

Review 10.  The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.

Authors:  Xiaofeng Li; Xiaozhou Yu; Dong Dai; Xiuyu Song; Wengui Xu
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.